Literature DB >> 6794774

Speech therapy for patients with Parkinson's disease.

S Scott, F I Caird.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 6794774      PMCID： PMC1507509          DOI： 10.1136/bmj.283.6299.1088

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  The third element of speech: prosody in the neuro-psychiatric clinic.

Authors:  G H MONRAD-KROHN
Journal:  J Ment Sci       Date:  1957-04

2.  Effect of L-dopa on speech in Parkinsonism. An EMG study of labial articulatory function.

Authors:  R Leanderson; B A Meyerson; A Persson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-12       Impact factor: 10.154
  2 in total
  7 in total

1.  Parkinson's disease: disability, review, and management.

Authors:  W J Mutch; A Strudwick; S K Roy; A W Downie
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  The response of the apparent receptive speech disorder of Parkinson's disease to speech therapy.

Authors:  S Scott; F I Caird
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

3.  Speech therapy for Parkinson's disease.

Authors:  S Scott; F I Caird
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

4.  Evidence for an apparent sensory speech disorder in Parkinson's disease.

Authors:  S Scott; F I Caird; B O Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

5.  Parkinson's disease: the spectrum of disabilities.

Authors:  B Pentland; M P Barnes; L J Findley; M Oxtoby; V R Pearce; N P Quinn; S Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  Idiopathic Parkinson's disease: epidemiology, diagnosis and management.

Authors:  Y Ben-Shlomo; K Sieradzan
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

7.  A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.

Authors:  C M Sackley; C Rick; P Au; M C Brady; G Beaton; C Burton; M Caulfield; S Dickson; F Dowling; M Hughes; N Ives; S Jowett; P Masterson-Algar; A Nicoll; S Patel; C H Smith; R Woolley; C E Clarke
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.